PureHealth invests US$612M in UAE local sourcing amid “Make it in the Emirates” push

UAE—PureHealth, the Middle East’s largest healthcare group, has announced that its total investment in locally sourced goods and services has reached AED 2.25 billion (US$612 million) as the 2025 edition of the “Make it in the Emirates” initiative begins.

 This milestone underscores PureHealth’s strong commitment to supporting the UAE’s national economy and advancing the country’s industrial and healthcare ambitions.

In 2024 alone, PureHealth invested AED 1 billion (US$272 million) into the UAE economy, marking a 38% increase compared to 2023.

This surge directly supports the UAE’s strategy to localize supply chains, promote national businesses, and accelerate economic diversification.

Since joining the Ministry of Industry and Advanced Technology (MoIAT) led National In-Country Value (ICV) Program in 2022, PureHealth has set an ambitious target to spend AED 13 billion (US$3.5 billion) on local procurement by 2032, and it is well on track to meet this goal.

PureHealth’s efforts align closely with the “Make it in the Emirates” initiative, a key pillar of the UAE’s national industrial strategy aimed at increasing the industrial sector’s GDP contribution to AED 300 billion (US$81.67 million) by 2031.

The group is actively expanding local sourcing, investing in advanced manufacturing, and forging strategic partnerships with Emirati enterprises to build a resilient and sustainable healthcare ecosystem.

Shaista Asif, Group CEO of PureHealth, emphasized that their investment is driven by a long-term vision for healthcare resilience.

She explained that by advancing their ICV goals, PureHealth is localizing critical supply chains, fostering homegrown innovation, and developing advanced healthcare manufacturing capabilities.

This approach is designed not only to meet current healthcare needs but also to establish a self-sufficient system that supports UAE communities for generations while contributing to the nation’s economic growth.

PureHealth’s commitment is reflected in the strong ICV performance of its subsidiaries. Abu Dhabi Health Services Company (SEHA) holds the highest ICV score in the UAE healthcare sector at 81.13%, while Daman, the leading health insurer, ranks second in the UAE insurance sector with a score of 71.86%.

Other group entities like PureLab and The Medical Office (TMO) have secured their ICV certifications, and Sheikh Shakhbout Medical City (SSMC) is expected to receive its certification later this year, moving the group closer to full compliance.

Leya Al Damani, Chief Sustainability Officer at PureHealth, highlighted the synergy between sustainability and localization.

She noted that partnering with UAE-based suppliers who meet environmental and quality standards creates long-term value for both the healthcare system and the national economy.

The National ICV Program provides a robust framework to scale this impact responsibly while supporting the growth of small and medium-sized enterprises across the country.

PureHealth’s procurement strategy covers medical supplies, pharmaceuticals, technology, and infrastructure services, with a strong focus on UAE-based suppliers that meet international standards and encourage innovation.

Through strategic agreements and supplier development, PureHealth continues to identify new opportunities to collaborate with local manufacturers, thereby enhancing industrial capacity, supply chain resilience, and the UAE’s vision for a future-ready healthcare sector.

Sign up HERE to receive our email newsletters with the latest news and insights from Africa and beyond. Also, follow us on our WhatsApp channel for updates.